MeiraGTx Holdings PLCNASDAQ:MGTX
- LAST PRICE7.8900
- TODAY'S CHANGE (%)-0.2700 (-3.3088%)
- Bid / Lots3.2200/ 2
- Ask / Lots8.0500/ 2
- Open / Previous Close8.1500 / 8.1600
- Day Range
- 52 Week Range
- Volume78,979
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MGTX |
|---|---|---|
| 09:32 ET | 1706 | 8.07 |
| 09:35 ET | 100 | 8.075 |
| 09:37 ET | 200 | 8.07 |
| 09:42 ET | 984 | 8.17 |
| 09:44 ET | 4426 | 8.15 |
| 09:46 ET | 200 | 8.16 |
| 09:48 ET | 400 | 8.155 |
| 09:50 ET | 300 | 8.105 |
| 09:51 ET | 300 | 8.15 |
| 09:57 ET | 1200 | 8.08 |
| 10:02 ET | 100 | 8.14 |
| 10:04 ET | 200 | 8.11 |
| 10:08 ET | 100 | 8.09 |
| 10:18 ET | 400 | 8.1 |
| 10:20 ET | 100 | 8.0626 |
| 10:22 ET | 100 | 8.1 |
| 10:24 ET | 776 | 8.18 |
| 10:29 ET | 1795 | 8.04 |
| 10:31 ET | 200 | 8.01 |
| 10:38 ET | 100 | 8.015 |
| 10:47 ET | 616 | 8.035 |
| 11:02 ET | 261 | 8.035 |
| 11:03 ET | 100 | 8.03 |
| 11:05 ET | 1100 | 8.06 |
| 11:18 ET | 1094 | 8.08 |
| 11:41 ET | 100 | 8.11 |
| 11:59 ET | 400 | 8.13 |
| 12:01 ET | 100 | 8.13 |
| 12:03 ET | 100 | 8.115 |
| 12:15 ET | 400 | 8.115 |
| 12:17 ET | 1186 | 8.03 |
| 12:24 ET | 100 | 8.045 |
| 12:28 ET | 391 | 8.0799 |
| 12:30 ET | 302 | 7.99 |
| 12:42 ET | 1028 | 8.02 |
| 12:44 ET | 300 | 7.98 |
| 12:48 ET | 300 | 8.03 |
| 12:51 ET | 200 | 8.01 |
| 12:53 ET | 100 | 8.02 |
| 12:57 ET | 100 | 8.03 |
| 01:02 ET | 100 | 8.09 |
| 01:09 ET | 3000 | 8.03 |
| 01:13 ET | 100 | 8.015 |
| 01:15 ET | 200 | 7.99 |
| 01:18 ET | 400 | 7.93 |
| 01:22 ET | 100 | 7.95 |
| 01:26 ET | 798 | 7.9 |
| 01:27 ET | 300 | 7.89 |
| 01:29 ET | 800 | 7.915 |
| 01:31 ET | 600 | 7.86 |
| 01:33 ET | 1200 | 7.78 |
| 01:36 ET | 100 | 7.815 |
| 01:38 ET | 200 | 7.78 |
| 01:40 ET | 100 | 7.79 |
| 01:42 ET | 100 | 7.8 |
| 01:51 ET | 100 | 7.71 |
| 02:02 ET | 500 | 7.74 |
| 02:05 ET | 100 | 7.74 |
| 02:07 ET | 100 | 7.79 |
| 02:09 ET | 200 | 7.785 |
| 02:18 ET | 400 | 7.85 |
| 02:23 ET | 200 | 7.8 |
| 02:32 ET | 800 | 7.82 |
| 02:34 ET | 100 | 7.81 |
| 02:38 ET | 200 | 7.835 |
| 02:41 ET | 200 | 7.825 |
| 02:45 ET | 100 | 7.815 |
| 03:01 ET | 400 | 7.855 |
| 03:03 ET | 600 | 7.84 |
| 03:06 ET | 1142 | 7.84 |
| 03:10 ET | 200 | 7.835 |
| 03:12 ET | 409 | 7.83 |
| 03:14 ET | 100 | 7.845 |
| 03:15 ET | 764 | 7.85 |
| 03:17 ET | 200 | 7.84 |
| 03:19 ET | 400 | 7.875 |
| 03:28 ET | 500 | 7.865 |
| 03:35 ET | 700 | 7.84 |
| 03:37 ET | 394 | 7.815 |
| 03:39 ET | 100 | 7.81 |
| 03:42 ET | 600 | 7.81 |
| 03:44 ET | 400 | 7.83 |
| 03:48 ET | 300 | 7.845 |
| 03:50 ET | 400 | 7.84 |
| 03:51 ET | 1008 | 7.885 |
| 03:53 ET | 400 | 7.9 |
| 03:55 ET | 1078 | 7.86 |
| 03:57 ET | 1100 | 7.86 |
| 04:00 ET | 12581 | 7.89 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
MeiraGTx Holdings PLC | 395.6M | -3.1x | --- |
Concert Pharmaceuticals Inc | 401.7M | -2.9x | --- |
G1 Therapeutics Inc | 375.9M | -2.2x | --- |
WAVE Life Sciences Ltd | 440.6M | -2.3x | --- |
ADC Therapeutics SA | 350.7M | -2.1x | --- |
Alpine Immune Sciences Inc | 365.0M | -4.3x | --- |
Company Information
MeiraGTx Holdings plc is an integrated clinical stage gene therapy company. The Company is focused on three areas of unmet medical needs, including inherited retinal diseases (IDs), as well as large degenerative ocular diseases, severe forms of xerostomia and neurodegenerative diseases. The Company’s products pipeline includes AAV-RPGR, which is for the treatment of x-linked retinitis pigmentosa (XLRP); AAV-hAQP1, which is for the treatment of grade two/three radiation-induced xerostomia; AAV-GAD, is for the treatment of Parkinson’s disease, and AAV-CNGB3 and AAV-CNGA3 for the treatment of Achromatopsia (ACHM). The Company has six programs in clinical development, including Phase I/Il clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa and RPE65-Deficiency, and Phase I clinical trials for radiation-induced xerostomia (RIX), and a Parkinson’s program that has completed a Phase II trial with published data.
Contact Information
- Headquarters
- 450 E 29th St Fl 15NEW YORK, NY, United States 10016-8367
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Keith Harris
- President, Chief Executive Officer, Director
- Alexandria Forbes
- Chief Financial Officer, Chief Operating Officer
- Richard Giroux
- General Counsel, Secretary
- Robert Wollin
- Chief Development Officer
- Stuart Naylor
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $395.6M |
|---|---|
Revenue (TTM) | $42.3M |
Shares Outstanding | 48.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.43 |
EPS | $-2.52 |
Book Value | $4.16 |
P/E Ratio | -3.1x |
Price/Sales (TTM) | 9.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -197.45% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
